Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+5.28%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
5.35%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| 1 |
Philip Morris
PM
|
+$27.3M |
| 2 |
AGN
Allergan plc
AGN
|
+$23.4M |
| 3 |
Toro Company
TTC
|
+$20.7M |
| 4 |
PepsiCo
PEP
|
+$19.7M |
| 5 |
Lockheed Martin
LMT
|
+$18.2M |
Top Sells
| 1 |
Intuit
INTU
|
+$26.9M |
| 2 |
Wells Fargo
WFC
|
+$20.2M |
| 3 |
Centene
CNC
|
+$19.4M |
| 4 |
Eli Lilly
LLY
|
+$16.5M |
| 5 |
Gilead Sciences
GILD
|
+$15.4M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.79% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Pure Storage
PSTG
$27B
| $440K | 0.01% |
+27,520
| New | +$440K |
|
727
Scansource
SCSC
$994M
| $440K | 0.01% |
10,090
-6,077
| -38% | -$265K |
|
|
SPNE
728
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $440K | 0.01% |
39,213
+9,937
| +34% | +$112K |
|
729
BioMarin Pharmaceuticals
BMRN
$10.7B
| $435K | 0.01% |
+4,670
| New | +$435K |
|
730
Akebia Therapeutics
AKBA
$793M
| $429K | 0.01% |
21,790
+2,310
| +12% | +$45.5K |
|
|
RUTH
731
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $427K | 0.01% |
20,401
| – | – |
|
732
Box
BOX
$4.78B
| $423K | 0.01% |
+21,910
| New | +$423K |
|
|
TVPT
733
DELISTED
Travelport Worldwide Limited
TVPT
| $412K | 0.01% |
26,239
+150
| +0.6% | +$2.36K |
|
|
MRLN
734
DELISTED
Marlin Business Services Corp
MRLN
| $409K | 0.01% |
14,240
+6,070
| +74% | +$174K |
|
735
Ingles Markets
IMKTA
$1.32B
| $406K | 0.01% |
+15,780
| New | +$406K |
|
736
Cidara Therapeutics
CDTX
$1.64B
| $405K | 0.01% |
2,503
-705
| -22% | -$114K |
|
737
Lineage Cell Therapeutics
LCTX
$295M
| $403K | 0.01% |
162,023
+30,568
| +23% | +$76K |
|
|
PCMI
738
DELISTED
PCM, Inc
PCMI
| $401K | 0.01% |
28,658
-7,880
| -22% | -$110K |
|
|
NPKI
739
NPK International Inc.
NPKI
$901M
| $398K | 0.01% |
+39,800
| New | +$398K |
|
740
Strategic Education
STRA
$2.02B
| $396K | 0.01% |
4,540
-1,230
| -21% | -$107K |
|
741
Consolidated Edison
ED
$35.2B
| $395K | 0.01% |
4,890
-400
| -8% | -$32.3K |
|
742
PC Connection
CNXN
$1.65B
| $388K | 0.01% |
13,760
-9,850
| -42% | -$278K |
|
743
Sierra Bancorp
BSRR
$416M
| $386K | 0.01% |
14,200
-1,500
| -10% | -$40.8K |
|
|
BELFB
744
Bel Fuse Class B
BELFB
$1.88B
| $385K | 0.01% |
12,351
-1,500
| -11% | -$46.8K |
|
|
EVRI
745
DELISTED
Everi Holdings
EVRI
| $385K | 0.01% |
50,730
-176,197
| -78% | -$1.34M |
|
746
Corcept Therapeutics
CORT
$7.83B
| $382K | 0.01% |
+19,810
| New | +$382K |
|
747
American Public Education
APEI
$638M
| $381K | 0.01% |
+18,100
| New | +$381K |
|
748
Conagra Brands
CAG
$9.31B
| $380K | 0.01% |
11,250
| – | – |
|
|
PTLA
749
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $376K | 0.01% |
6,950
-8,260
| -54% | -$447K |
|
|
TLRA
750
DELISTED
Telaria, Inc.
TLRA
| $365K | 0.01% |
83,705
-4,300
| -5% | -$18.8K |
|